103470-60-6

Basic information

• Product Name: (3R,4S,5S,6S)-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octane-5,6-diol
• CAS NO: 103470-60-6
• Molecular Formula: C₁₅H₂₄O₄
• Molecular Weight: 268.3487
• Mol File: 103470-60-6.mol

Chemical Properties

• Boiling Point: 401.2°C at 760 mmHg
• Flash Point: 196.4°C
• Density: 1.2g/cm³
• Vapor Pressure: 4.19E-08mmHg at 25°C
• Refractive Index: 1.553
• CAS DataBase Reference: (3R,4S,5S,6S)-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octane-5,6-diol(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,4S,5S,6S)-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octane-5,6-diol(103470-60-6)
• EPA Substance Registry System: (3R,4S,5S,6S)-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octane-5,6-diol(103470-60-6)

Safety Data

• Hazardous Substances Data: 103470-60-6(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(3R,4S,5S,6S)-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octane-5,6-diol is used as a key intermediate in organic synthesis for the development of novel compounds with potential applications in various fields.
Used in Medicinal Chemistry:
(3R,4S,5S,6S)-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octane-5,6-diol is used as a building block in the design and synthesis of new pharmaceutical agents, leveraging its unique structure and functional groups to create molecules with potential therapeutic properties.
Used in Biochemical Research:
(3R,4S,5S,6S)-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octane-5,6-diol is used as a research tool in biochemical studies to investigate its interactions with biological systems and explore its potential as a probe for understanding complex biological processes.

Upstream product

• 210765-11-0 (3R,4S,5S,6S)-4-<(1E)-1,5-dimethylhexa-1,4-dien-1-yl>-1-oxaspiro<2.5>octane-5.6-diol 
• 877052-59-0 (3R,4S,5S)-5-Hydroxy-4-[(2R,3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]octan-6-one 
• 851764-31-3 (R)-4-hydroxy-1,4-dioxa-spiro[4.5]decan-8-one 
• 877052-52-3 4-(tert-butyl-dimethyl-silanyloxymethyl)-4-hydroxy-cyclohex-2-enone 
• 877052-51-2 (7R,8R)-7,8-Bis-trimethylsilanyloxy-1,4-dioxa-spiro[4.5]decane-8-carbaldehyde 
• 877052-54-5 (2S,3S,4R)-3-((E)-1,5-Dimethyl-hexa-1,4-dienyl)-2,4-dihydroxy-4-hydroxymethyl-cyclohexanone 
• 877052-50-1 (7R,8S)-7,8-Bis-trimethylsilanyloxy-1,4-dioxa-spiro[4.5]decane-8-carbonitrile 
• 877052-53-4 (1R,2R)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-2-((E)-1,5-dimethyl-hexa-1,4-dienyl)-4-trimethylsilanyloxy-cyclohex-3-enol 
• 877052-55-6 Toluene-4-sulfonic acid (1R,2S,3S)-2-((E)-1,5-dimethyl-hexa-1,4-dienyl)-1,3-dihydroxy-4-oxo-cyclohexylmethyl ester 
• 210765-04-1 (2E)-3-<(1S,2S,3S,6R)-6-(tert-butyldimethylsilyl)oxy-2,3-di-(4-methoxybenzyl)oxy-cyclohex-1-yl>but-2-enal 
• 210765-07-4 (2E)-3-<(3R,4S,5S,6S)-5,6-di-(4-methoxybenzyl)oxy-1-oxaspiro<2.5>oct-4-yl>-1-(tert-butyldimethylsilyl)oxybut-2-ene 
• 222545-17-7 Dithiocarbonic acid O-[(1R,2S,5S,6R)-5,6-bis-(4-methoxy-benzyloxy)-2-(tetrahydro-pyran-2-yloxy)-cyclohex-3-enyl] ester S-methyl ester 
• 210764-95-7 (3S,4R,5R,6S)-5-acetoxy-3,4-di-(4-methoxybenzyl)oxy-6-(tetrahydropyran-2-yl)oxycyclohex-1-ene 
• 210765-06-3 (2S,3S,4S)-2-<(1E)-3-(tert-butyldimethylsilyl)oxy-1-methylprop-1-en-1-yl>-3,4-di-(4-methoxybenzyl)oxy-cyclohexan-1-one 

Relevant articles and documents

Concise enantio- and diastereoselective total syntheses of fumagillol, RK-805, FR65814, ovalicin, and 5-demethylovalicin

(Chemical Equation Presented) L-Proline-mediated α-aminoxylation is a key step in the enantio- and diastereoselective total syntheses of fumagillin, ovalicin, and related compounds (see scheme). These compounds contain a cyclohexane ring, two epoxides, an

Chiral and stereoselective total synthesis of novel immunosuppressant FR65814 from D-glucose

The chiral synthesis of the immunosuppressive sesquiterpene, FR65814 1 is described. The cyclohexane ring in 1 was prepared in an optically active form from D-glucose using Ferrier's carbocyclization reaction, and the carbon side-chain in 1 was stereoselectively introduced via chirality transfer by way of Claisen rearrangement of the cyclohexenol derivative, followed by Pd- catalyzed Stille coupling. The bis-epoxide function was stereoselectively constructed by sulfur ylide chemistry and vanadium catalyzed epoxidation of a homoallyl alcohol derivative. This first total synthesis fully confirmed the proposed absolute structure of FR65814.

Total synthesis and absolute configuration of FR65814

The chiral and highly stereoselective synthesis of FR658141, a novel immunosuppressant, starting from D-glucose is described; this first total synthesis fully confirms the proposed structure of 1.